Elsevier

Journal of Electrocardiology

Volume 51, Issue 6, November–December 2018, Pages 1039-1043
Journal of Electrocardiology

Association between typical electrocardiographic abnormalities and NT-proBNP elevation in a large cohort of patients with Chagas disease from endemic area

https://doi.org/10.1016/j.jelectrocard.2018.08.031Get rights and content

Highlights

  • Describes electrocardiograms of a large cohort of patients with Chagas disease

  • Typical ECG alterations of Chagas disease have greater odds of NT-proBNP elevation.

  • Men had more major ECG abnormalities than women.

  • The ECG is a simple and accurate method to predict Chagas disease severity.

Abstract

Chagas cardiomyopathy is the most harmful complication of Chagas disease. The electrocardiogram is a well-studied exam and has been considered an important tool for detection and evaluation of Chagas cardiomyopathy since the first years of its description. Many of its abnormalities have been described as associated with a worse prognosis. Serum BNP levels were described as inversely related to the left ventricular ejection fraction and as an independent predictor of death. It was not reported how electrocardiographic alterations correlate to NT-proBNP and its analog. The present study aims to describe the baseline electrocardiograms of a large cohort of patients with Chagas disease from endemic area and to establish an association between the number of electrocardiogram alterations and high levels of NT-ProBNP in Chagas disease patients. This study selected 1959 Chagas disease patients in 21 municipalities within a limited region in the northern part of the State of Minas Gerais (Brazil), 1084 of them had Chagas cardiomyopathy. NT-proBNP levels were suggestive of heart failure in 11.7% of this population. One or more electrocardiographic alterations have an Odds Ratio of 9.12 (CI 95% 5.62–14.80) to have NT-proBNP elevation. Considering the association between the number of 1, 2, and 3 or more alterations in electrocardiogram and NT-proBNP elevation, the ORs were 7.11 (CI 95% 4.33–11.67); 16.04 (CI 95% 9.27–27.77) and 47.82 (CI 95% 17.98–127.20), respectively. The presence and the number of typical electrocardiographic alterations of Chagas disease are independently associated with the severity of the cardiomyopathy.

Introduction

Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and remains a health problem despite the partial control of its transmission. The World Health Organization estimates that approximately 8 million people have been infected, particularly in Latin America where the disease is endemic. In recent decades, the epidemiological profile has changed due to migratory movements, which has led to both the urbanization and globalization of the disease. There are nearly 300,000 infected people in USA, and 30,000 to 45,000 of these individuals have an unrecognized form of Chagas cardiomyopathy (ChCM) according to the Centers for Disease Control and Prevention [1,2].

ChCM is the most harmful complication of Chagas disease. Its annual incidence among the patients with indeterminate form is 1.85 per 100 people-years [3]. Many exams, which can easily be performed on outpatients, provide valuable information about both the prognosis of ChCM and the presence of left ventricular systolic dysfunction. Serum BNP levels were described as inversely related to the left ventricular ejection fraction, with a high positive predictive value of 80% and an even higher negative predictive value of 97% to identify those patients with low left ventricular ejection fraction [4]. The BNP, or its analog, NT-proBNP, was also described as a marker of ventricular arrhythmias [5], and diastolic dysfunction [6,7], as well as an independent predictor of death [8]. Therefore, considering these results, we assumed that high BNP levels are associated with heart failure (HF) and could be considered a surrogate marker of this condition.

The electrocardiogram (ECG) is a well-studied exam and has been considered an important tool for detection and evaluation of ChCM since the first years of its description [9]. Many of its abnormalities have been described as associated with a worse prognosis in ChCM and the need of further evaluation [[10], [11], [12], [13]]. However, it is not reported how electrocardiographic alterations correlate to BNP. Because the ECG has a low cost and is a widely available exam, it can be useful in identifying those patients with a higher probability for NT-ProBNP alterations. Therefore, the present study, aims to describe the baseline electrocardiograms of a large cohort of patients with Chagas disease from a endemic area, named São Paulo-Minas Gerais Tropical Medicine Research Center cohort (SaMi-Trop Study), and to establish an association between the number of ECG alterations evaluated according to the Minnesota Code and high levels of NT-ProBNP in T. cruzi chronically infected individuals [14].

Section snippets

Study design

This report is a cross-sectional descriptive study of ECGs and serum NT-proBNP obtained from the baseline of a large cohort of patients with Chagas disease from endemic area named SaMi-Trop Study [14]. The SaMi-Trop consists of a network of collaborating scientists in the States of Minas Gerais and São Paulo and has been established to develop and conduct research projects on Chagas disease. The SaMi-Trop study is a prospective cohort begun in 2013 with at least two years of follow-up. The

Results

The clinical characteristics of the participants are listed in Table 1. Most of this population consisted of women and low-income participants. Almost 25% have used Benzonidazol to treat Chagas disease. NT-proBNP levels were suggestive of HF in 11.7% of this population.

The electrocardiographic parameters and measurements stratified by sex and by NT-proBNP levels are described in Table 2. The elevated NT-pro BNP group has a different median QRS duration, PR interval, QTc interval (Hodges), QRS,

Discussion

This cross-sectional population-based study showed that men have more frequent electrocardiographic abnormalities than women, and that these alterations occur more often in the group with high NT-proBNP levels. The presence of major ECG abnormalities increases the odds of NT-proBNP elevation, and this relation becomes stronger if more than one abnormality coexists. Those who showed any major abnormality on the electrocardiogram had a risk of 8.12 times higher to NT-proBNP elevation. This

Conclusion

The most frequent abnormalities identified in the patients who had the Chagas cardiomyopathy are in accordance to other important populational studies. Men had more major ECG abnormalities than women. Typical electrocardiographic alterations of Chagas disease are related to greater odds of NT-proBNP elevation, which is a marker of the severity of the cardiomyopathy. This association presents no major changes even if we consider other cardiovascular risk factors, gender and age.

Declarations of interest

None.

References (32)

  • J.H. Maguire et al.

    Relationship of electrocardiographic abnormalities and seropositivity to Trypanosoma cruzi within a rural community in Northeast Brazil

    Am Heart J

    (1983)
  • M.S. Marcolino et al.

    Electrocardiogram and Chagas disease: a large population database of primary care patients

    Glob Heart

    (2015)
  • M.S. Marcolino et al.

    Frequent electrocardiographic abnormalities and associated conditions in Chagas disease patients

    J Electrocardiol

    (2013)
  • C.Y. Liu et al.

    Association of Elevated NT-proBNP with myocardial fibrosis in the Multi-Ethnic Study of Atherosclerosis (MESA)

    J Am Coll Cardiol

    (2017)
  • A.L. Ribeiro et al.

    Diagnosis and management of Chagas disease and cardiomyopathy

    Nat Rev Cardiol

    (2012)
  • E.C. Sabino et al.

    Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors

    Circulation

    (2013)
  • The SaMi-Trop cohort study is supported by The National Institutes of Health-NIH, P50 AI098461-02.

    1

    A.L.P.R. receives unrestricted grants from CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil) and FAPEMIG (Fundação de Amparo à Pesquisa de Minas Gerais, Brazil).

    View full text